We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.585 | 0.60 | 0.65 | - | 347,222 | 08:31:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -29.00 | 12.86M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/11/2017 07:57 | Libra, the point is that the link was a click through on social Media !!!!@~!, it goes on to suggest some FF products..... Regardless of your opinion on how effective the product is at lowering BP or improving bloodflow this is an effective marketing campaign and 99% of successful marketing to the wider population is perception. This will add to the bottom line for the company....... | senor_sensible | |
16/11/2017 15:49 | Provexis are planning to launch Fruitflow plus in USA see website for details. | lafin | |
16/11/2017 15:46 | Different news about high blood pressure "The definition of high blood pressure has been revised, meaning that more Americans are now classified as hypertensive. Almost half of adults in the United States could now be classified as having high blood pressure, after new guidelines from the American Heart Association and the American College of Cardiology have redefined the condition." | lafin | |
16/11/2017 15:40 | text from above link " The new study involved 12 men with a slightly elevated blood pressure in the prehypertensive range (systolic blood pressure 120–139 mmHg, diastolic blood pressure 80–89 mmHg). On two separate occasions, they were randomised to take either a single 150mg dose of Fruitflow tomato extract, or a placebo, so acted as their own controls. After taking the supplements, each volunteer had their blood pressure measured for 24 hours via an Ambulatory Blood Pressure monitor (every 30 minutes during the day, and hourly during the night). The single dose of Fruitflow resulted in the men having an average blood pressure that was 8/5 mmHg lower than when they took the placebo. The blood pressure monitors also tagged each systolic blood pressure reading (upper value) that spiked above 135 mmHg while awake or above 120mmHg while asleep. For diastolic blood pressure (lower reading), values were tagged if they spiked above 85 mmHg while awake or 70 mmHg during sleep. Overall, the number of blood pressure spikes experienced by the study group were reduced by 57% (systolic) and 27% (diastolic) after taking Fruitflow compared with the placebo. These effects were apparent throughout the day and night, and the changes were sufficient to move the men from the prehypertensive into the normotensive (normal blood pressure) category. Placebo Fruitflow Reduction with Fruitflow 24 hour average BP: 126/81 mmHg 118/76 mmHg – 8/5 mmHg Waking average BP: 130/84 mmHg 121/78 mmHg – 9/6 mmHg Sleeping average BP: 112/70 mmHg 106/67 mmHg – 6/3 mmHg According to Dr Asim Duttaroy, of the University of Oslo’s Faculty of Medicine, ‘To the untrained eye, these figures may seem like small variations, but data from US colleagues suggests that from a public health standpoint, every 1 mmHg reduction in systolic blood pressure could prevent approximately 10,000 coronary heart disease deaths each year.’ As with previous trials, the study also showed that taking Fruitflow has a positive effect on platelet function. Before taking Fruitflow, the men’s average platelet function showed that 82% aggregated when stimulated, while after taking Fruitflow this went down to only 68%, meaning that the tomato extract can help to reduce unwanted blood clots. There’s every reason to presume that Fruitflow tomato extracts will have beneficial effects on blood pressure in women, too, if I’m anything to go by!" | lafin | |
16/11/2017 15:06 | I wonder what happened in 2017 | lafin | |
16/11/2017 15:04 | Do you have any evidence it is not 2017? | lafin | |
16/11/2017 15:03 | I don't know what the idiot above wrote, but it's best ignored ... | librag | |
16/11/2017 14:58 | Only because you are a very blinkered individual who thinks he speaks for the whole of mankind. Well I've got news for you-------. This is 2017. | lafin | |
16/11/2017 14:36 | Fruitflow lowers blood pressure. There's no evidence it lowers high blood pressure. Rather unfortunately. :( | librag | |
16/11/2017 14:24 | hxxps://mylowerblood | senor_sensible | |
13/11/2017 13:50 | I've just been showing the graph to my OH. Normally she says sell, send money back to that black hole called our current a/c. Grrr. This time, bless her cotton socks, she says look at the 5 year chart for 1.4p in short shrift. Agreed, re. 0.7p and fingers crossed. CNKS on the bid and set at 0.9p offer. GL. | librag | |
13/11/2017 13:05 | Libra, some tough resistance at the 0.7 to 0.75p range, but once through that not much between this and 1.4p. About a month off Results day wich always seems to add to momentum. News flow is good and the technicals look good, not often they are alligned, that coupled with this being oversold could mean a rocket over coming weeks..... | senor_sensible | |
13/11/2017 12:45 | SS; It's early days I think but hopefully you're right. >1p'ish and my blood pressure will be back to normal. :) GL. | librag | |
13/11/2017 08:23 | strong buy.... IMO will have a new 52 week high before the year is out. | senor_sensible | |
13/11/2017 08:14 | Libra, IMO this is the one you have been waiting for...... long term signal is strong buy and signal strength is maximum...... :-) | senor_sensible | |
12/11/2017 02:18 | Closer To China:- On t.v program tonight a news program called "Closer to China" they talked about the latest 25.3 billion dollar trade deal between China and America, the highest ever, and stated this is just the beginning and non Chinese companies can now, in a joint venture, can partner in 51% of the joint venture. Now we all know DSM/Provexis is in a collaboration deal with the Chinese company By-Health to produce and sell new Fruitflow products, and that could now become a Joint Venture, and in China due to lower labor costs, profit margins will be higher, and in a joint venture By-Health and DSM and Provexis can come together and make one hell of a giant global and profitable company selling in China and around the world. . And its no co-incidence, in my opinion, Provexis share price has just risen as the possible knock on effects of this Closer to China agreement and possible Joint Venture between DSM and Provexis and By-Health and 51% shared partnership is realized. | wheelds | |
11/11/2017 00:37 | Libra. Value investing in AIM companies is an artform, an artform which is learnt expensively hence those with impatience and/or short term horizons can struggle. Its a perfect battlefield for traders with the right software, skill, experience and DMA. To assess a company, forming an idea of funding requirements (dilution etc), revenue and potential buyout valuation and so on is incredibly problematic. Yes I prefer to interact socially with individuals with well stocked minds but here I am only really interested in learning from the successes and failures of others. To be honest we are all probably unconsciously deluding ourselves re failures and achievments in investing. Most of the best investors and traders never waste their time on these futile boards. | gunsofmarscapone | |
10/11/2017 20:48 | Let's hope so ... but while we have dross like this over on the blue channel, I worry. "NoR slow climber, hope not. Buck and Ford aren’t in this for the salary, they want the jackpot when they are young enough to enjoy it. An RNS could drop anytime with an offer we would find difficult to turn down. Asshur once said FF was worth a billion - b4 blood pressure, b4 nitrates, b4 ED - maybe soeone would like it for 100 mill ? W$" Asshair was an idiot but congratulations, you've trumped him. | librag | |
10/11/2017 19:47 | So something in the weekends press perhaps....buying today and subsequent rise would suggest as much. Let's see.... DL | davidlloyd | |
10/11/2017 17:53 | sleveen; absolutely and n=12! | librag | |
10/11/2017 17:19 | INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2017 hxxps://doi.org/10.1 Not quite Lancet or NEJM standard. | sleveen |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions